Medical Care
Global Cell and Gene Therapy Bioassay Services Market Research Report 2025
- May 12, 25
- ID: 236270
- Pages: 85
- Figures: 85
- Views: 7
The global market for Cell and Gene Therapy Bioassay Services was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Cell and Gene Therapy Bioassay Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cell and Gene Therapy Bioassay Services.
The Cell and Gene Therapy Bioassay Services market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cell and Gene Therapy Bioassay Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cell and Gene Therapy Bioassay Services companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Anabiotec
Ccrm
Nexelis
Pacific Biolabs
Ppd Laboratories
Intertek Pharmaceutical Services
Lonza
Porton Biopharma Ltd
Wuxi Advanced Therapies
Avomeen
Charles River Laboratories
Absorption Systems
Bioagilytix Labs
Catalent Inc
Svar Life Science Ab
Segment by Type
Cell Therapy
Gene Therapy
Segment by Application
Pharmaceutical Company
Biotechnology
Others
Mucopolysaccharidosis (MPS) Type lV A
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cell and Gene Therapy Bioassay Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Cell and Gene Therapy Bioassay Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cell and Gene Therapy Bioassay Services.
The Cell and Gene Therapy Bioassay Services market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cell and Gene Therapy Bioassay Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cell and Gene Therapy Bioassay Services companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Anabiotec
Ccrm
Nexelis
Pacific Biolabs
Ppd Laboratories
Intertek Pharmaceutical Services
Lonza
Porton Biopharma Ltd
Wuxi Advanced Therapies
Avomeen
Charles River Laboratories
Absorption Systems
Bioagilytix Labs
Catalent Inc
Svar Life Science Ab
Segment by Type
Cell Therapy
Gene Therapy
Segment by Application
Pharmaceutical Company
Biotechnology
Others
Mucopolysaccharidosis (MPS) Type lV A
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cell and Gene Therapy Bioassay Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell and Gene Therapy Bioassay Services Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Cell Therapy
1.2.3 Gene Therapy
1.3 Market by Application
1.3.1 Global Cell and Gene Therapy Bioassay Services Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical Company
1.3.3 Biotechnology
1.3.4 Others
1.3.5 Mucopolysaccharidosis (MPS) Type lV A
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cell and Gene Therapy Bioassay Services Market Perspective (2020-2031)
2.2 Global Cell and Gene Therapy Bioassay Services Growth Trends by Region
2.2.1 Global Cell and Gene Therapy Bioassay Services Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Cell and Gene Therapy Bioassay Services Historic Market Size by Region (2020-2025)
2.2.3 Cell and Gene Therapy Bioassay Services Forecasted Market Size by Region (2026-2031)
2.3 Cell and Gene Therapy Bioassay Services Market Dynamics
2.3.1 Cell and Gene Therapy Bioassay Services Industry Trends
2.3.2 Cell and Gene Therapy Bioassay Services Market Drivers
2.3.3 Cell and Gene Therapy Bioassay Services Market Challenges
2.3.4 Cell and Gene Therapy Bioassay Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cell and Gene Therapy Bioassay Services Players by Revenue
3.1.1 Global Top Cell and Gene Therapy Bioassay Services Players by Revenue (2020-2025)
3.1.2 Global Cell and Gene Therapy Bioassay Services Revenue Market Share by Players (2020-2025)
3.2 Global Cell and Gene Therapy Bioassay Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Cell and Gene Therapy Bioassay Services Revenue
3.4 Global Cell and Gene Therapy Bioassay Services Market Concentration Ratio
3.4.1 Global Cell and Gene Therapy Bioassay Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell and Gene Therapy Bioassay Services Revenue in 2024
3.5 Global Key Players of Cell and Gene Therapy Bioassay Services Head office and Area Served
3.6 Global Key Players of Cell and Gene Therapy Bioassay Services, Product and Application
3.7 Global Key Players of Cell and Gene Therapy Bioassay Services, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cell and Gene Therapy Bioassay Services Breakdown Data by Type
4.1 Global Cell and Gene Therapy Bioassay Services Historic Market Size by Type (2020-2025)
4.2 Global Cell and Gene Therapy Bioassay Services Forecasted Market Size by Type (2026-2031)
5 Cell and Gene Therapy Bioassay Services Breakdown Data by Application
5.1 Global Cell and Gene Therapy Bioassay Services Historic Market Size by Application (2020-2025)
5.2 Global Cell and Gene Therapy Bioassay Services Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Cell and Gene Therapy Bioassay Services Market Size (2020-2031)
6.2 North America Cell and Gene Therapy Bioassay Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Cell and Gene Therapy Bioassay Services Market Size by Country (2020-2025)
6.4 North America Cell and Gene Therapy Bioassay Services Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cell and Gene Therapy Bioassay Services Market Size (2020-2031)
7.2 Europe Cell and Gene Therapy Bioassay Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Cell and Gene Therapy Bioassay Services Market Size by Country (2020-2025)
7.4 Europe Cell and Gene Therapy Bioassay Services Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cell and Gene Therapy Bioassay Services Market Size (2020-2031)
8.2 Asia-Pacific Cell and Gene Therapy Bioassay Services Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Cell and Gene Therapy Bioassay Services Market Size by Region (2020-2025)
8.4 Asia-Pacific Cell and Gene Therapy Bioassay Services Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cell and Gene Therapy Bioassay Services Market Size (2020-2031)
9.2 Latin America Cell and Gene Therapy Bioassay Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Cell and Gene Therapy Bioassay Services Market Size by Country (2020-2025)
9.4 Latin America Cell and Gene Therapy Bioassay Services Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cell and Gene Therapy Bioassay Services Market Size (2020-2031)
10.2 Middle East & Africa Cell and Gene Therapy Bioassay Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Cell and Gene Therapy Bioassay Services Market Size by Country (2020-2025)
10.4 Middle East & Africa Cell and Gene Therapy Bioassay Services Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Anabiotec
11.1.1 Anabiotec Company Details
11.1.2 Anabiotec Business Overview
11.1.3 Anabiotec Cell and Gene Therapy Bioassay Services Introduction
11.1.4 Anabiotec Revenue in Cell and Gene Therapy Bioassay Services Business (2020-2025)
11.1.5 Anabiotec Recent Development
11.2 Ccrm
11.2.1 Ccrm Company Details
11.2.2 Ccrm Business Overview
11.2.3 Ccrm Cell and Gene Therapy Bioassay Services Introduction
11.2.4 Ccrm Revenue in Cell and Gene Therapy Bioassay Services Business (2020-2025)
11.2.5 Ccrm Recent Development
11.3 Nexelis
11.3.1 Nexelis Company Details
11.3.2 Nexelis Business Overview
11.3.3 Nexelis Cell and Gene Therapy Bioassay Services Introduction
11.3.4 Nexelis Revenue in Cell and Gene Therapy Bioassay Services Business (2020-2025)
11.3.5 Nexelis Recent Development
11.4 Pacific Biolabs
11.4.1 Pacific Biolabs Company Details
11.4.2 Pacific Biolabs Business Overview
11.4.3 Pacific Biolabs Cell and Gene Therapy Bioassay Services Introduction
11.4.4 Pacific Biolabs Revenue in Cell and Gene Therapy Bioassay Services Business (2020-2025)
11.4.5 Pacific Biolabs Recent Development
11.5 Ppd Laboratories
11.5.1 Ppd Laboratories Company Details
11.5.2 Ppd Laboratories Business Overview
11.5.3 Ppd Laboratories Cell and Gene Therapy Bioassay Services Introduction
11.5.4 Ppd Laboratories Revenue in Cell and Gene Therapy Bioassay Services Business (2020-2025)
11.5.5 Ppd Laboratories Recent Development
11.6 Intertek Pharmaceutical Services
11.6.1 Intertek Pharmaceutical Services Company Details
11.6.2 Intertek Pharmaceutical Services Business Overview
11.6.3 Intertek Pharmaceutical Services Cell and Gene Therapy Bioassay Services Introduction
11.6.4 Intertek Pharmaceutical Services Revenue in Cell and Gene Therapy Bioassay Services Business (2020-2025)
11.6.5 Intertek Pharmaceutical Services Recent Development
11.7 Lonza
11.7.1 Lonza Company Details
11.7.2 Lonza Business Overview
11.7.3 Lonza Cell and Gene Therapy Bioassay Services Introduction
11.7.4 Lonza Revenue in Cell and Gene Therapy Bioassay Services Business (2020-2025)
11.7.5 Lonza Recent Development
11.8 Porton Biopharma Ltd
11.8.1 Porton Biopharma Ltd Company Details
11.8.2 Porton Biopharma Ltd Business Overview
11.8.3 Porton Biopharma Ltd Cell and Gene Therapy Bioassay Services Introduction
11.8.4 Porton Biopharma Ltd Revenue in Cell and Gene Therapy Bioassay Services Business (2020-2025)
11.8.5 Porton Biopharma Ltd Recent Development
11.9 Wuxi Advanced Therapies
11.9.1 Wuxi Advanced Therapies Company Details
11.9.2 Wuxi Advanced Therapies Business Overview
11.9.3 Wuxi Advanced Therapies Cell and Gene Therapy Bioassay Services Introduction
11.9.4 Wuxi Advanced Therapies Revenue in Cell and Gene Therapy Bioassay Services Business (2020-2025)
11.9.5 Wuxi Advanced Therapies Recent Development
11.10 Avomeen
11.10.1 Avomeen Company Details
11.10.2 Avomeen Business Overview
11.10.3 Avomeen Cell and Gene Therapy Bioassay Services Introduction
11.10.4 Avomeen Revenue in Cell and Gene Therapy Bioassay Services Business (2020-2025)
11.10.5 Avomeen Recent Development
11.11 Charles River Laboratories
11.11.1 Charles River Laboratories Company Details
11.11.2 Charles River Laboratories Business Overview
11.11.3 Charles River Laboratories Cell and Gene Therapy Bioassay Services Introduction
11.11.4 Charles River Laboratories Revenue in Cell and Gene Therapy Bioassay Services Business (2020-2025)
11.11.5 Charles River Laboratories Recent Development
11.12 Absorption Systems
11.12.1 Absorption Systems Company Details
11.12.2 Absorption Systems Business Overview
11.12.3 Absorption Systems Cell and Gene Therapy Bioassay Services Introduction
11.12.4 Absorption Systems Revenue in Cell and Gene Therapy Bioassay Services Business (2020-2025)
11.12.5 Absorption Systems Recent Development
11.13 Bioagilytix Labs
11.13.1 Bioagilytix Labs Company Details
11.13.2 Bioagilytix Labs Business Overview
11.13.3 Bioagilytix Labs Cell and Gene Therapy Bioassay Services Introduction
11.13.4 Bioagilytix Labs Revenue in Cell and Gene Therapy Bioassay Services Business (2020-2025)
11.13.5 Bioagilytix Labs Recent Development
11.14 Catalent Inc
11.14.1 Catalent Inc Company Details
11.14.2 Catalent Inc Business Overview
11.14.3 Catalent Inc Cell and Gene Therapy Bioassay Services Introduction
11.14.4 Catalent Inc Revenue in Cell and Gene Therapy Bioassay Services Business (2020-2025)
11.14.5 Catalent Inc Recent Development
11.15 Svar Life Science Ab
11.15.1 Svar Life Science Ab Company Details
11.15.2 Svar Life Science Ab Business Overview
11.15.3 Svar Life Science Ab Cell and Gene Therapy Bioassay Services Introduction
11.15.4 Svar Life Science Ab Revenue in Cell and Gene Therapy Bioassay Services Business (2020-2025)
11.15.5 Svar Life Science Ab Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell and Gene Therapy Bioassay Services Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Cell Therapy
1.2.3 Gene Therapy
1.3 Market by Application
1.3.1 Global Cell and Gene Therapy Bioassay Services Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical Company
1.3.3 Biotechnology
1.3.4 Others
1.3.5 Mucopolysaccharidosis (MPS) Type lV A
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cell and Gene Therapy Bioassay Services Market Perspective (2020-2031)
2.2 Global Cell and Gene Therapy Bioassay Services Growth Trends by Region
2.2.1 Global Cell and Gene Therapy Bioassay Services Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Cell and Gene Therapy Bioassay Services Historic Market Size by Region (2020-2025)
2.2.3 Cell and Gene Therapy Bioassay Services Forecasted Market Size by Region (2026-2031)
2.3 Cell and Gene Therapy Bioassay Services Market Dynamics
2.3.1 Cell and Gene Therapy Bioassay Services Industry Trends
2.3.2 Cell and Gene Therapy Bioassay Services Market Drivers
2.3.3 Cell and Gene Therapy Bioassay Services Market Challenges
2.3.4 Cell and Gene Therapy Bioassay Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cell and Gene Therapy Bioassay Services Players by Revenue
3.1.1 Global Top Cell and Gene Therapy Bioassay Services Players by Revenue (2020-2025)
3.1.2 Global Cell and Gene Therapy Bioassay Services Revenue Market Share by Players (2020-2025)
3.2 Global Cell and Gene Therapy Bioassay Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Cell and Gene Therapy Bioassay Services Revenue
3.4 Global Cell and Gene Therapy Bioassay Services Market Concentration Ratio
3.4.1 Global Cell and Gene Therapy Bioassay Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell and Gene Therapy Bioassay Services Revenue in 2024
3.5 Global Key Players of Cell and Gene Therapy Bioassay Services Head office and Area Served
3.6 Global Key Players of Cell and Gene Therapy Bioassay Services, Product and Application
3.7 Global Key Players of Cell and Gene Therapy Bioassay Services, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cell and Gene Therapy Bioassay Services Breakdown Data by Type
4.1 Global Cell and Gene Therapy Bioassay Services Historic Market Size by Type (2020-2025)
4.2 Global Cell and Gene Therapy Bioassay Services Forecasted Market Size by Type (2026-2031)
5 Cell and Gene Therapy Bioassay Services Breakdown Data by Application
5.1 Global Cell and Gene Therapy Bioassay Services Historic Market Size by Application (2020-2025)
5.2 Global Cell and Gene Therapy Bioassay Services Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Cell and Gene Therapy Bioassay Services Market Size (2020-2031)
6.2 North America Cell and Gene Therapy Bioassay Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Cell and Gene Therapy Bioassay Services Market Size by Country (2020-2025)
6.4 North America Cell and Gene Therapy Bioassay Services Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cell and Gene Therapy Bioassay Services Market Size (2020-2031)
7.2 Europe Cell and Gene Therapy Bioassay Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Cell and Gene Therapy Bioassay Services Market Size by Country (2020-2025)
7.4 Europe Cell and Gene Therapy Bioassay Services Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cell and Gene Therapy Bioassay Services Market Size (2020-2031)
8.2 Asia-Pacific Cell and Gene Therapy Bioassay Services Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Cell and Gene Therapy Bioassay Services Market Size by Region (2020-2025)
8.4 Asia-Pacific Cell and Gene Therapy Bioassay Services Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cell and Gene Therapy Bioassay Services Market Size (2020-2031)
9.2 Latin America Cell and Gene Therapy Bioassay Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Cell and Gene Therapy Bioassay Services Market Size by Country (2020-2025)
9.4 Latin America Cell and Gene Therapy Bioassay Services Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cell and Gene Therapy Bioassay Services Market Size (2020-2031)
10.2 Middle East & Africa Cell and Gene Therapy Bioassay Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Cell and Gene Therapy Bioassay Services Market Size by Country (2020-2025)
10.4 Middle East & Africa Cell and Gene Therapy Bioassay Services Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Anabiotec
11.1.1 Anabiotec Company Details
11.1.2 Anabiotec Business Overview
11.1.3 Anabiotec Cell and Gene Therapy Bioassay Services Introduction
11.1.4 Anabiotec Revenue in Cell and Gene Therapy Bioassay Services Business (2020-2025)
11.1.5 Anabiotec Recent Development
11.2 Ccrm
11.2.1 Ccrm Company Details
11.2.2 Ccrm Business Overview
11.2.3 Ccrm Cell and Gene Therapy Bioassay Services Introduction
11.2.4 Ccrm Revenue in Cell and Gene Therapy Bioassay Services Business (2020-2025)
11.2.5 Ccrm Recent Development
11.3 Nexelis
11.3.1 Nexelis Company Details
11.3.2 Nexelis Business Overview
11.3.3 Nexelis Cell and Gene Therapy Bioassay Services Introduction
11.3.4 Nexelis Revenue in Cell and Gene Therapy Bioassay Services Business (2020-2025)
11.3.5 Nexelis Recent Development
11.4 Pacific Biolabs
11.4.1 Pacific Biolabs Company Details
11.4.2 Pacific Biolabs Business Overview
11.4.3 Pacific Biolabs Cell and Gene Therapy Bioassay Services Introduction
11.4.4 Pacific Biolabs Revenue in Cell and Gene Therapy Bioassay Services Business (2020-2025)
11.4.5 Pacific Biolabs Recent Development
11.5 Ppd Laboratories
11.5.1 Ppd Laboratories Company Details
11.5.2 Ppd Laboratories Business Overview
11.5.3 Ppd Laboratories Cell and Gene Therapy Bioassay Services Introduction
11.5.4 Ppd Laboratories Revenue in Cell and Gene Therapy Bioassay Services Business (2020-2025)
11.5.5 Ppd Laboratories Recent Development
11.6 Intertek Pharmaceutical Services
11.6.1 Intertek Pharmaceutical Services Company Details
11.6.2 Intertek Pharmaceutical Services Business Overview
11.6.3 Intertek Pharmaceutical Services Cell and Gene Therapy Bioassay Services Introduction
11.6.4 Intertek Pharmaceutical Services Revenue in Cell and Gene Therapy Bioassay Services Business (2020-2025)
11.6.5 Intertek Pharmaceutical Services Recent Development
11.7 Lonza
11.7.1 Lonza Company Details
11.7.2 Lonza Business Overview
11.7.3 Lonza Cell and Gene Therapy Bioassay Services Introduction
11.7.4 Lonza Revenue in Cell and Gene Therapy Bioassay Services Business (2020-2025)
11.7.5 Lonza Recent Development
11.8 Porton Biopharma Ltd
11.8.1 Porton Biopharma Ltd Company Details
11.8.2 Porton Biopharma Ltd Business Overview
11.8.3 Porton Biopharma Ltd Cell and Gene Therapy Bioassay Services Introduction
11.8.4 Porton Biopharma Ltd Revenue in Cell and Gene Therapy Bioassay Services Business (2020-2025)
11.8.5 Porton Biopharma Ltd Recent Development
11.9 Wuxi Advanced Therapies
11.9.1 Wuxi Advanced Therapies Company Details
11.9.2 Wuxi Advanced Therapies Business Overview
11.9.3 Wuxi Advanced Therapies Cell and Gene Therapy Bioassay Services Introduction
11.9.4 Wuxi Advanced Therapies Revenue in Cell and Gene Therapy Bioassay Services Business (2020-2025)
11.9.5 Wuxi Advanced Therapies Recent Development
11.10 Avomeen
11.10.1 Avomeen Company Details
11.10.2 Avomeen Business Overview
11.10.3 Avomeen Cell and Gene Therapy Bioassay Services Introduction
11.10.4 Avomeen Revenue in Cell and Gene Therapy Bioassay Services Business (2020-2025)
11.10.5 Avomeen Recent Development
11.11 Charles River Laboratories
11.11.1 Charles River Laboratories Company Details
11.11.2 Charles River Laboratories Business Overview
11.11.3 Charles River Laboratories Cell and Gene Therapy Bioassay Services Introduction
11.11.4 Charles River Laboratories Revenue in Cell and Gene Therapy Bioassay Services Business (2020-2025)
11.11.5 Charles River Laboratories Recent Development
11.12 Absorption Systems
11.12.1 Absorption Systems Company Details
11.12.2 Absorption Systems Business Overview
11.12.3 Absorption Systems Cell and Gene Therapy Bioassay Services Introduction
11.12.4 Absorption Systems Revenue in Cell and Gene Therapy Bioassay Services Business (2020-2025)
11.12.5 Absorption Systems Recent Development
11.13 Bioagilytix Labs
11.13.1 Bioagilytix Labs Company Details
11.13.2 Bioagilytix Labs Business Overview
11.13.3 Bioagilytix Labs Cell and Gene Therapy Bioassay Services Introduction
11.13.4 Bioagilytix Labs Revenue in Cell and Gene Therapy Bioassay Services Business (2020-2025)
11.13.5 Bioagilytix Labs Recent Development
11.14 Catalent Inc
11.14.1 Catalent Inc Company Details
11.14.2 Catalent Inc Business Overview
11.14.3 Catalent Inc Cell and Gene Therapy Bioassay Services Introduction
11.14.4 Catalent Inc Revenue in Cell and Gene Therapy Bioassay Services Business (2020-2025)
11.14.5 Catalent Inc Recent Development
11.15 Svar Life Science Ab
11.15.1 Svar Life Science Ab Company Details
11.15.2 Svar Life Science Ab Business Overview
11.15.3 Svar Life Science Ab Cell and Gene Therapy Bioassay Services Introduction
11.15.4 Svar Life Science Ab Revenue in Cell and Gene Therapy Bioassay Services Business (2020-2025)
11.15.5 Svar Life Science Ab Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Cell and Gene Therapy Bioassay Services Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Cell Therapy
Table 3. Key Players of Gene Therapy
Table 4. Global Cell and Gene Therapy Bioassay Services Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Cell and Gene Therapy Bioassay Services Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Cell and Gene Therapy Bioassay Services Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Cell and Gene Therapy Bioassay Services Market Share by Region (2020-2025)
Table 8. Global Cell and Gene Therapy Bioassay Services Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Cell and Gene Therapy Bioassay Services Market Share by Region (2026-2031)
Table 10. Cell and Gene Therapy Bioassay Services Market Trends
Table 11. Cell and Gene Therapy Bioassay Services Market Drivers
Table 12. Cell and Gene Therapy Bioassay Services Market Challenges
Table 13. Cell and Gene Therapy Bioassay Services Market Restraints
Table 14. Global Cell and Gene Therapy Bioassay Services Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Cell and Gene Therapy Bioassay Services Market Share by Players (2020-2025)
Table 16. Global Top Cell and Gene Therapy Bioassay Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell and Gene Therapy Bioassay Services as of 2024)
Table 17. Ranking of Global Top Cell and Gene Therapy Bioassay Services Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Cell and Gene Therapy Bioassay Services Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Cell and Gene Therapy Bioassay Services, Headquarters and Area Served
Table 20. Global Key Players of Cell and Gene Therapy Bioassay Services, Product and Application
Table 21. Global Key Players of Cell and Gene Therapy Bioassay Services, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Cell and Gene Therapy Bioassay Services Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Cell and Gene Therapy Bioassay Services Revenue Market Share by Type (2020-2025)
Table 25. Global Cell and Gene Therapy Bioassay Services Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Cell and Gene Therapy Bioassay Services Revenue Market Share by Type (2026-2031)
Table 27. Global Cell and Gene Therapy Bioassay Services Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Cell and Gene Therapy Bioassay Services Revenue Market Share by Application (2020-2025)
Table 29. Global Cell and Gene Therapy Bioassay Services Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Cell and Gene Therapy Bioassay Services Revenue Market Share by Application (2026-2031)
Table 31. North America Cell and Gene Therapy Bioassay Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Cell and Gene Therapy Bioassay Services Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Cell and Gene Therapy Bioassay Services Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Cell and Gene Therapy Bioassay Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Cell and Gene Therapy Bioassay Services Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Cell and Gene Therapy Bioassay Services Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Cell and Gene Therapy Bioassay Services Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Cell and Gene Therapy Bioassay Services Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Cell and Gene Therapy Bioassay Services Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Cell and Gene Therapy Bioassay Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Cell and Gene Therapy Bioassay Services Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Cell and Gene Therapy Bioassay Services Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Cell and Gene Therapy Bioassay Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Cell and Gene Therapy Bioassay Services Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Cell and Gene Therapy Bioassay Services Market Size by Country (2026-2031) & (US$ Million)
Table 46. Anabiotec Company Details
Table 47. Anabiotec Business Overview
Table 48. Anabiotec Cell and Gene Therapy Bioassay Services Product
Table 49. Anabiotec Revenue in Cell and Gene Therapy Bioassay Services Business (2020-2025) & (US$ Million)
Table 50. Anabiotec Recent Development
Table 51. Ccrm Company Details
Table 52. Ccrm Business Overview
Table 53. Ccrm Cell and Gene Therapy Bioassay Services Product
Table 54. Ccrm Revenue in Cell and Gene Therapy Bioassay Services Business (2020-2025) & (US$ Million)
Table 55. Ccrm Recent Development
Table 56. Nexelis Company Details
Table 57. Nexelis Business Overview
Table 58. Nexelis Cell and Gene Therapy Bioassay Services Product
Table 59. Nexelis Revenue in Cell and Gene Therapy Bioassay Services Business (2020-2025) & (US$ Million)
Table 60. Nexelis Recent Development
Table 61. Pacific Biolabs Company Details
Table 62. Pacific Biolabs Business Overview
Table 63. Pacific Biolabs Cell and Gene Therapy Bioassay Services Product
Table 64. Pacific Biolabs Revenue in Cell and Gene Therapy Bioassay Services Business (2020-2025) & (US$ Million)
Table 65. Pacific Biolabs Recent Development
Table 66. Ppd Laboratories Company Details
Table 67. Ppd Laboratories Business Overview
Table 68. Ppd Laboratories Cell and Gene Therapy Bioassay Services Product
Table 69. Ppd Laboratories Revenue in Cell and Gene Therapy Bioassay Services Business (2020-2025) & (US$ Million)
Table 70. Ppd Laboratories Recent Development
Table 71. Intertek Pharmaceutical Services Company Details
Table 72. Intertek Pharmaceutical Services Business Overview
Table 73. Intertek Pharmaceutical Services Cell and Gene Therapy Bioassay Services Product
Table 74. Intertek Pharmaceutical Services Revenue in Cell and Gene Therapy Bioassay Services Business (2020-2025) & (US$ Million)
Table 75. Intertek Pharmaceutical Services Recent Development
Table 76. Lonza Company Details
Table 77. Lonza Business Overview
Table 78. Lonza Cell and Gene Therapy Bioassay Services Product
Table 79. Lonza Revenue in Cell and Gene Therapy Bioassay Services Business (2020-2025) & (US$ Million)
Table 80. Lonza Recent Development
Table 81. Porton Biopharma Ltd Company Details
Table 82. Porton Biopharma Ltd Business Overview
Table 83. Porton Biopharma Ltd Cell and Gene Therapy Bioassay Services Product
Table 84. Porton Biopharma Ltd Revenue in Cell and Gene Therapy Bioassay Services Business (2020-2025) & (US$ Million)
Table 85. Porton Biopharma Ltd Recent Development
Table 86. Wuxi Advanced Therapies Company Details
Table 87. Wuxi Advanced Therapies Business Overview
Table 88. Wuxi Advanced Therapies Cell and Gene Therapy Bioassay Services Product
Table 89. Wuxi Advanced Therapies Revenue in Cell and Gene Therapy Bioassay Services Business (2020-2025) & (US$ Million)
Table 90. Wuxi Advanced Therapies Recent Development
Table 91. Avomeen Company Details
Table 92. Avomeen Business Overview
Table 93. Avomeen Cell and Gene Therapy Bioassay Services Product
Table 94. Avomeen Revenue in Cell and Gene Therapy Bioassay Services Business (2020-2025) & (US$ Million)
Table 95. Avomeen Recent Development
Table 96. Charles River Laboratories Company Details
Table 97. Charles River Laboratories Business Overview
Table 98. Charles River Laboratories Cell and Gene Therapy Bioassay Services Product
Table 99. Charles River Laboratories Revenue in Cell and Gene Therapy Bioassay Services Business (2020-2025) & (US$ Million)
Table 100. Charles River Laboratories Recent Development
Table 101. Absorption Systems Company Details
Table 102. Absorption Systems Business Overview
Table 103. Absorption Systems Cell and Gene Therapy Bioassay Services Product
Table 104. Absorption Systems Revenue in Cell and Gene Therapy Bioassay Services Business (2020-2025) & (US$ Million)
Table 105. Absorption Systems Recent Development
Table 106. Bioagilytix Labs Company Details
Table 107. Bioagilytix Labs Business Overview
Table 108. Bioagilytix Labs Cell and Gene Therapy Bioassay Services Product
Table 109. Bioagilytix Labs Revenue in Cell and Gene Therapy Bioassay Services Business (2020-2025) & (US$ Million)
Table 110. Bioagilytix Labs Recent Development
Table 111. Catalent Inc Company Details
Table 112. Catalent Inc Business Overview
Table 113. Catalent Inc Cell and Gene Therapy Bioassay Services Product
Table 114. Catalent Inc Revenue in Cell and Gene Therapy Bioassay Services Business (2020-2025) & (US$ Million)
Table 115. Catalent Inc Recent Development
Table 116. Svar Life Science Ab Company Details
Table 117. Svar Life Science Ab Business Overview
Table 118. Svar Life Science Ab Cell and Gene Therapy Bioassay Services Product
Table 119. Svar Life Science Ab Revenue in Cell and Gene Therapy Bioassay Services Business (2020-2025) & (US$ Million)
Table 120. Svar Life Science Ab Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
Table 124. Authors List of This Report
List of Figures
Figure 1. Cell and Gene Therapy Bioassay Services Picture
Figure 2. Global Cell and Gene Therapy Bioassay Services Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Cell and Gene Therapy Bioassay Services Market Share by Type: 2024 VS 2031
Figure 4. Cell Therapy Features
Figure 5. Gene Therapy Features
Figure 6. Global Cell and Gene Therapy Bioassay Services Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Cell and Gene Therapy Bioassay Services Market Share by Application: 2024 VS 2031
Figure 8. Pharmaceutical Company Case Studies
Figure 9. Biotechnology Case Studies
Figure 10. Others Case Studies
Figure 11. Mucopolysaccharidosis (MPS) Type lV A Case Studies
Figure 12. Others Case Studies
Figure 13. Cell and Gene Therapy Bioassay Services Report Years Considered
Figure 14. Global Cell and Gene Therapy Bioassay Services Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Cell and Gene Therapy Bioassay Services Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Cell and Gene Therapy Bioassay Services Market Share by Region: 2024 VS 2031
Figure 17. Global Cell and Gene Therapy Bioassay Services Market Share by Players in 2024
Figure 18. Global Top Cell and Gene Therapy Bioassay Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell and Gene Therapy Bioassay Services as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Cell and Gene Therapy Bioassay Services Revenue in 2024
Figure 20. North America Cell and Gene Therapy Bioassay Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Cell and Gene Therapy Bioassay Services Market Share by Country (2020-2031)
Figure 22. United States Cell and Gene Therapy Bioassay Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Cell and Gene Therapy Bioassay Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Cell and Gene Therapy Bioassay Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Cell and Gene Therapy Bioassay Services Market Share by Country (2020-2031)
Figure 26. Germany Cell and Gene Therapy Bioassay Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Cell and Gene Therapy Bioassay Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Cell and Gene Therapy Bioassay Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Cell and Gene Therapy Bioassay Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Cell and Gene Therapy Bioassay Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Cell and Gene Therapy Bioassay Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Cell and Gene Therapy Bioassay Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Cell and Gene Therapy Bioassay Services Market Share by Region (2020-2031)
Figure 34. China Cell and Gene Therapy Bioassay Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Cell and Gene Therapy Bioassay Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Cell and Gene Therapy Bioassay Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Cell and Gene Therapy Bioassay Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Cell and Gene Therapy Bioassay Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Cell and Gene Therapy Bioassay Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Cell and Gene Therapy Bioassay Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Cell and Gene Therapy Bioassay Services Market Share by Country (2020-2031)
Figure 42. Mexico Cell and Gene Therapy Bioassay Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Cell and Gene Therapy Bioassay Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Cell and Gene Therapy Bioassay Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Cell and Gene Therapy Bioassay Services Market Share by Country (2020-2031)
Figure 46. Turkey Cell and Gene Therapy Bioassay Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Cell and Gene Therapy Bioassay Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Cell and Gene Therapy Bioassay Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Anabiotec Revenue Growth Rate in Cell and Gene Therapy Bioassay Services Business (2020-2025)
Figure 50. Ccrm Revenue Growth Rate in Cell and Gene Therapy Bioassay Services Business (2020-2025)
Figure 51. Nexelis Revenue Growth Rate in Cell and Gene Therapy Bioassay Services Business (2020-2025)
Figure 52. Pacific Biolabs Revenue Growth Rate in Cell and Gene Therapy Bioassay Services Business (2020-2025)
Figure 53. Ppd Laboratories Revenue Growth Rate in Cell and Gene Therapy Bioassay Services Business (2020-2025)
Figure 54. Intertek Pharmaceutical Services Revenue Growth Rate in Cell and Gene Therapy Bioassay Services Business (2020-2025)
Figure 55. Lonza Revenue Growth Rate in Cell and Gene Therapy Bioassay Services Business (2020-2025)
Figure 56. Porton Biopharma Ltd Revenue Growth Rate in Cell and Gene Therapy Bioassay Services Business (2020-2025)
Figure 57. Wuxi Advanced Therapies Revenue Growth Rate in Cell and Gene Therapy Bioassay Services Business (2020-2025)
Figure 58. Avomeen Revenue Growth Rate in Cell and Gene Therapy Bioassay Services Business (2020-2025)
Figure 59. Charles River Laboratories Revenue Growth Rate in Cell and Gene Therapy Bioassay Services Business (2020-2025)
Figure 60. Absorption Systems Revenue Growth Rate in Cell and Gene Therapy Bioassay Services Business (2020-2025)
Figure 61. Bioagilytix Labs Revenue Growth Rate in Cell and Gene Therapy Bioassay Services Business (2020-2025)
Figure 62. Catalent Inc Revenue Growth Rate in Cell and Gene Therapy Bioassay Services Business (2020-2025)
Figure 63. Svar Life Science Ab Revenue Growth Rate in Cell and Gene Therapy Bioassay Services Business (2020-2025)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Table 1. Global Cell and Gene Therapy Bioassay Services Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Cell Therapy
Table 3. Key Players of Gene Therapy
Table 4. Global Cell and Gene Therapy Bioassay Services Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Cell and Gene Therapy Bioassay Services Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Cell and Gene Therapy Bioassay Services Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Cell and Gene Therapy Bioassay Services Market Share by Region (2020-2025)
Table 8. Global Cell and Gene Therapy Bioassay Services Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Cell and Gene Therapy Bioassay Services Market Share by Region (2026-2031)
Table 10. Cell and Gene Therapy Bioassay Services Market Trends
Table 11. Cell and Gene Therapy Bioassay Services Market Drivers
Table 12. Cell and Gene Therapy Bioassay Services Market Challenges
Table 13. Cell and Gene Therapy Bioassay Services Market Restraints
Table 14. Global Cell and Gene Therapy Bioassay Services Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Cell and Gene Therapy Bioassay Services Market Share by Players (2020-2025)
Table 16. Global Top Cell and Gene Therapy Bioassay Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell and Gene Therapy Bioassay Services as of 2024)
Table 17. Ranking of Global Top Cell and Gene Therapy Bioassay Services Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Cell and Gene Therapy Bioassay Services Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Cell and Gene Therapy Bioassay Services, Headquarters and Area Served
Table 20. Global Key Players of Cell and Gene Therapy Bioassay Services, Product and Application
Table 21. Global Key Players of Cell and Gene Therapy Bioassay Services, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Cell and Gene Therapy Bioassay Services Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Cell and Gene Therapy Bioassay Services Revenue Market Share by Type (2020-2025)
Table 25. Global Cell and Gene Therapy Bioassay Services Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Cell and Gene Therapy Bioassay Services Revenue Market Share by Type (2026-2031)
Table 27. Global Cell and Gene Therapy Bioassay Services Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Cell and Gene Therapy Bioassay Services Revenue Market Share by Application (2020-2025)
Table 29. Global Cell and Gene Therapy Bioassay Services Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Cell and Gene Therapy Bioassay Services Revenue Market Share by Application (2026-2031)
Table 31. North America Cell and Gene Therapy Bioassay Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Cell and Gene Therapy Bioassay Services Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Cell and Gene Therapy Bioassay Services Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Cell and Gene Therapy Bioassay Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Cell and Gene Therapy Bioassay Services Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Cell and Gene Therapy Bioassay Services Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Cell and Gene Therapy Bioassay Services Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Cell and Gene Therapy Bioassay Services Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Cell and Gene Therapy Bioassay Services Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Cell and Gene Therapy Bioassay Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Cell and Gene Therapy Bioassay Services Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Cell and Gene Therapy Bioassay Services Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Cell and Gene Therapy Bioassay Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Cell and Gene Therapy Bioassay Services Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Cell and Gene Therapy Bioassay Services Market Size by Country (2026-2031) & (US$ Million)
Table 46. Anabiotec Company Details
Table 47. Anabiotec Business Overview
Table 48. Anabiotec Cell and Gene Therapy Bioassay Services Product
Table 49. Anabiotec Revenue in Cell and Gene Therapy Bioassay Services Business (2020-2025) & (US$ Million)
Table 50. Anabiotec Recent Development
Table 51. Ccrm Company Details
Table 52. Ccrm Business Overview
Table 53. Ccrm Cell and Gene Therapy Bioassay Services Product
Table 54. Ccrm Revenue in Cell and Gene Therapy Bioassay Services Business (2020-2025) & (US$ Million)
Table 55. Ccrm Recent Development
Table 56. Nexelis Company Details
Table 57. Nexelis Business Overview
Table 58. Nexelis Cell and Gene Therapy Bioassay Services Product
Table 59. Nexelis Revenue in Cell and Gene Therapy Bioassay Services Business (2020-2025) & (US$ Million)
Table 60. Nexelis Recent Development
Table 61. Pacific Biolabs Company Details
Table 62. Pacific Biolabs Business Overview
Table 63. Pacific Biolabs Cell and Gene Therapy Bioassay Services Product
Table 64. Pacific Biolabs Revenue in Cell and Gene Therapy Bioassay Services Business (2020-2025) & (US$ Million)
Table 65. Pacific Biolabs Recent Development
Table 66. Ppd Laboratories Company Details
Table 67. Ppd Laboratories Business Overview
Table 68. Ppd Laboratories Cell and Gene Therapy Bioassay Services Product
Table 69. Ppd Laboratories Revenue in Cell and Gene Therapy Bioassay Services Business (2020-2025) & (US$ Million)
Table 70. Ppd Laboratories Recent Development
Table 71. Intertek Pharmaceutical Services Company Details
Table 72. Intertek Pharmaceutical Services Business Overview
Table 73. Intertek Pharmaceutical Services Cell and Gene Therapy Bioassay Services Product
Table 74. Intertek Pharmaceutical Services Revenue in Cell and Gene Therapy Bioassay Services Business (2020-2025) & (US$ Million)
Table 75. Intertek Pharmaceutical Services Recent Development
Table 76. Lonza Company Details
Table 77. Lonza Business Overview
Table 78. Lonza Cell and Gene Therapy Bioassay Services Product
Table 79. Lonza Revenue in Cell and Gene Therapy Bioassay Services Business (2020-2025) & (US$ Million)
Table 80. Lonza Recent Development
Table 81. Porton Biopharma Ltd Company Details
Table 82. Porton Biopharma Ltd Business Overview
Table 83. Porton Biopharma Ltd Cell and Gene Therapy Bioassay Services Product
Table 84. Porton Biopharma Ltd Revenue in Cell and Gene Therapy Bioassay Services Business (2020-2025) & (US$ Million)
Table 85. Porton Biopharma Ltd Recent Development
Table 86. Wuxi Advanced Therapies Company Details
Table 87. Wuxi Advanced Therapies Business Overview
Table 88. Wuxi Advanced Therapies Cell and Gene Therapy Bioassay Services Product
Table 89. Wuxi Advanced Therapies Revenue in Cell and Gene Therapy Bioassay Services Business (2020-2025) & (US$ Million)
Table 90. Wuxi Advanced Therapies Recent Development
Table 91. Avomeen Company Details
Table 92. Avomeen Business Overview
Table 93. Avomeen Cell and Gene Therapy Bioassay Services Product
Table 94. Avomeen Revenue in Cell and Gene Therapy Bioassay Services Business (2020-2025) & (US$ Million)
Table 95. Avomeen Recent Development
Table 96. Charles River Laboratories Company Details
Table 97. Charles River Laboratories Business Overview
Table 98. Charles River Laboratories Cell and Gene Therapy Bioassay Services Product
Table 99. Charles River Laboratories Revenue in Cell and Gene Therapy Bioassay Services Business (2020-2025) & (US$ Million)
Table 100. Charles River Laboratories Recent Development
Table 101. Absorption Systems Company Details
Table 102. Absorption Systems Business Overview
Table 103. Absorption Systems Cell and Gene Therapy Bioassay Services Product
Table 104. Absorption Systems Revenue in Cell and Gene Therapy Bioassay Services Business (2020-2025) & (US$ Million)
Table 105. Absorption Systems Recent Development
Table 106. Bioagilytix Labs Company Details
Table 107. Bioagilytix Labs Business Overview
Table 108. Bioagilytix Labs Cell and Gene Therapy Bioassay Services Product
Table 109. Bioagilytix Labs Revenue in Cell and Gene Therapy Bioassay Services Business (2020-2025) & (US$ Million)
Table 110. Bioagilytix Labs Recent Development
Table 111. Catalent Inc Company Details
Table 112. Catalent Inc Business Overview
Table 113. Catalent Inc Cell and Gene Therapy Bioassay Services Product
Table 114. Catalent Inc Revenue in Cell and Gene Therapy Bioassay Services Business (2020-2025) & (US$ Million)
Table 115. Catalent Inc Recent Development
Table 116. Svar Life Science Ab Company Details
Table 117. Svar Life Science Ab Business Overview
Table 118. Svar Life Science Ab Cell and Gene Therapy Bioassay Services Product
Table 119. Svar Life Science Ab Revenue in Cell and Gene Therapy Bioassay Services Business (2020-2025) & (US$ Million)
Table 120. Svar Life Science Ab Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
Table 124. Authors List of This Report
List of Figures
Figure 1. Cell and Gene Therapy Bioassay Services Picture
Figure 2. Global Cell and Gene Therapy Bioassay Services Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Cell and Gene Therapy Bioassay Services Market Share by Type: 2024 VS 2031
Figure 4. Cell Therapy Features
Figure 5. Gene Therapy Features
Figure 6. Global Cell and Gene Therapy Bioassay Services Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Cell and Gene Therapy Bioassay Services Market Share by Application: 2024 VS 2031
Figure 8. Pharmaceutical Company Case Studies
Figure 9. Biotechnology Case Studies
Figure 10. Others Case Studies
Figure 11. Mucopolysaccharidosis (MPS) Type lV A Case Studies
Figure 12. Others Case Studies
Figure 13. Cell and Gene Therapy Bioassay Services Report Years Considered
Figure 14. Global Cell and Gene Therapy Bioassay Services Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Cell and Gene Therapy Bioassay Services Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Cell and Gene Therapy Bioassay Services Market Share by Region: 2024 VS 2031
Figure 17. Global Cell and Gene Therapy Bioassay Services Market Share by Players in 2024
Figure 18. Global Top Cell and Gene Therapy Bioassay Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell and Gene Therapy Bioassay Services as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Cell and Gene Therapy Bioassay Services Revenue in 2024
Figure 20. North America Cell and Gene Therapy Bioassay Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Cell and Gene Therapy Bioassay Services Market Share by Country (2020-2031)
Figure 22. United States Cell and Gene Therapy Bioassay Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Cell and Gene Therapy Bioassay Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Cell and Gene Therapy Bioassay Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Cell and Gene Therapy Bioassay Services Market Share by Country (2020-2031)
Figure 26. Germany Cell and Gene Therapy Bioassay Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Cell and Gene Therapy Bioassay Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Cell and Gene Therapy Bioassay Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Cell and Gene Therapy Bioassay Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Cell and Gene Therapy Bioassay Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Cell and Gene Therapy Bioassay Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Cell and Gene Therapy Bioassay Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Cell and Gene Therapy Bioassay Services Market Share by Region (2020-2031)
Figure 34. China Cell and Gene Therapy Bioassay Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Cell and Gene Therapy Bioassay Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Cell and Gene Therapy Bioassay Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Cell and Gene Therapy Bioassay Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Cell and Gene Therapy Bioassay Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Cell and Gene Therapy Bioassay Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Cell and Gene Therapy Bioassay Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Cell and Gene Therapy Bioassay Services Market Share by Country (2020-2031)
Figure 42. Mexico Cell and Gene Therapy Bioassay Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Cell and Gene Therapy Bioassay Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Cell and Gene Therapy Bioassay Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Cell and Gene Therapy Bioassay Services Market Share by Country (2020-2031)
Figure 46. Turkey Cell and Gene Therapy Bioassay Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Cell and Gene Therapy Bioassay Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Cell and Gene Therapy Bioassay Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Anabiotec Revenue Growth Rate in Cell and Gene Therapy Bioassay Services Business (2020-2025)
Figure 50. Ccrm Revenue Growth Rate in Cell and Gene Therapy Bioassay Services Business (2020-2025)
Figure 51. Nexelis Revenue Growth Rate in Cell and Gene Therapy Bioassay Services Business (2020-2025)
Figure 52. Pacific Biolabs Revenue Growth Rate in Cell and Gene Therapy Bioassay Services Business (2020-2025)
Figure 53. Ppd Laboratories Revenue Growth Rate in Cell and Gene Therapy Bioassay Services Business (2020-2025)
Figure 54. Intertek Pharmaceutical Services Revenue Growth Rate in Cell and Gene Therapy Bioassay Services Business (2020-2025)
Figure 55. Lonza Revenue Growth Rate in Cell and Gene Therapy Bioassay Services Business (2020-2025)
Figure 56. Porton Biopharma Ltd Revenue Growth Rate in Cell and Gene Therapy Bioassay Services Business (2020-2025)
Figure 57. Wuxi Advanced Therapies Revenue Growth Rate in Cell and Gene Therapy Bioassay Services Business (2020-2025)
Figure 58. Avomeen Revenue Growth Rate in Cell and Gene Therapy Bioassay Services Business (2020-2025)
Figure 59. Charles River Laboratories Revenue Growth Rate in Cell and Gene Therapy Bioassay Services Business (2020-2025)
Figure 60. Absorption Systems Revenue Growth Rate in Cell and Gene Therapy Bioassay Services Business (2020-2025)
Figure 61. Bioagilytix Labs Revenue Growth Rate in Cell and Gene Therapy Bioassay Services Business (2020-2025)
Figure 62. Catalent Inc Revenue Growth Rate in Cell and Gene Therapy Bioassay Services Business (2020-2025)
Figure 63. Svar Life Science Ab Revenue Growth Rate in Cell and Gene Therapy Bioassay Services Business (2020-2025)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Allergen Detection Market Research Report 2025
Jun 28, 25
Global Electronic Health Tracking System Market Research Report 2025
Jun 28, 25
Global Speciality Optical Fibers Market Research Report 2025
Jun 28, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232